Literature DB >> 58200

Bromocriptine treatment of secondary amenorrhoea.

M Seppalå, E Hirvonen, T Ranta.   

Abstract

Bromocriptine 2-5 mg twice daily is effective in the treatment of both normoprolactinaemic and hyperprolactinaemic secondary amenorrhoea. This was demonstrated by the restoration of menstrual cycle and/or ovulation in 9 of 18 normoprolactinaemic and in 8 of 14 hyperprolactinaemic patients taking bromocriptine. Serum-prolactin level decreased in both groups of patients, and usually menstruation was recovered within 8 weeks'treatment. Galactorrhoea disappeared in 7 of 9 hyperprolactinaemic patients, and 2 became pregnant. After treatment had ceased spontaneous menstrual activity continued in 4 patients. 16 patients had side-effects the commonest being nausea and vertigo. These usually disappeared with the dosage was reduced, but 5 patients refused to continue. These results point to a new approach in the treatment of secondary amenorrhoea, even in those patients whose clinical findings give no indication of prolactin suppression.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 58200     DOI: 10.1016/s0140-6736(76)91542-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

1.  Bromocriptine in the treatment of the premenstrual syndrome.

Authors:  A N Andersen; J F Larsen
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

2.  Effect of bromocriptine on gonadal ornithine decarboxylase in vitro.

Authors:  P G Shah; A R Sheth
Journal:  Experientia       Date:  1979-12-15

3.  Serum prolactin and progesterone concentrations in ovulatory infertility.

Authors:  T Ranta; P Lehtovirta; U H Stenman; M Seppälä
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

4.  Plasma pituitary hormones in patients with Parkinson's disease treated with bromocriptine.

Authors:  M T Hyyppä; V A Långvik; U K Rinne
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

Review 5.  Bromocriptine in the treatment of hypogonadism and male impotence.

Authors:  C M March
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

Review 6.  Use of bromocriptine in hyperprolactinaemic anovulation and related disorders.

Authors:  S Franks
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

7.  Binding of antiparkinsonian ergot derivatives to the dopamine receptor.

Authors:  R L Weir; R E Hruska; E K Silbergeld
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.